Cure My Disease

Don't miss your cure!

 Log in / Sign up

C-Section pain relief showdown: spinal drug vs. nerve block

NCT ID NCT07374133

Symptom relief Sponsor: Ondokuz Mayıs University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 60 women having planned cesarean deliveries to compare two pain relief methods: giving morphine through the spinal needle versus a numbing injection near the belly muscles. The main goal was to see how many women needed extra pain medicine in the first 24 hours after surgery. The researchers also tracked pain scores, side effects like nausea and itching, and overall recovery quality.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

60 people

The number who actually took part.

Started

Feb 2026

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of parturients aged 18-45 years undergoing elective cesarean delivery under spinal anesthesia at a single tertiary care center. Participants are followed prospectively as a single observational cohort, and postoperative outcomes are compared between exposure groups defined by the routine clinical analgesic approach, including intrathecal morphine or ultrasound-guided bilateral transversalis fascia plane block.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female parturients aged 18 to 45 years * Gestational age greater than 37 weeks * American Society of Anesthesiologists (ASA) physical status II * Scheduled for elective cesarean delivery under spinal anesthesia * Willingness to participate in the study Exclusion Criteria: * Refusal to participate in the study * Cesarean delivery performed under general anesthesia * Conversion to general anesthesia after spinal anesthesia * ASA physical status greater than III * Multiple pregnancy * Contraindications to central or peripheral regional anesthesia techniques * Body mass index (BMI) greater than 35 kg/m² * Known allergy or hypersensitivity to local anesthetics or opioids * Presence of significant organ dysfunction (e.g., severe hepatic or renal disease)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cesarean delivery are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cesarean delivery Obstetric anesthesia Postoperative analgesia

Contacts and locations

Locations

  • Giresun University Faculty of Medicine

    Giresun, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.